World-First Trial Offers New Hope For Type 1 Diabetes

World-First Trial Offers New Hope For Type 1 Diabetes

Eurasia Review

Published

Researchers at St Vincent’s Institute of Medical Research (SVI) in Melbourne have shown that a commonly prescribed rheumatoid arthritis drug can suppress the progression of type 1 diabetes.  

The world-first human trial, published in the New England Journal of Medicine and led by SVI’s Professor Thomas Kay, showed...

Full Article